Login
Navigate Fool.com
Will NBS beat
the market?

Neostem, Inc.

NASDAQ: NBS

Community Rating: 3 Stars: Appealing

6.90 0.15 (2.22%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $6.70
Previous Close $6.75
Daily Range $6.69 - $6.95
52-Week Range $5.00 - $9.89
Market Cap $197.2M
P/E Ratio -3.55
Dividend (Yield) $0.06 (0.0%)
Ex-Dividend Date
Dividend Pay Date
01/01/70
01/01/70
Volume 245,244
Average Daily Volume 335,916
Current FY EPS -$1.36

How do you think NBS
will perform against the market?

Top NBS Bull/Bear Pitches

 

GasparOP (0)
Submitted March 14, 2011

Neostem is making serious medical progress in an area that is right now cutting-edge and will later be commonplace, fitting my investment philosophy completely, It uses adult stem cells, which is enc … More

1 Replies Reply Report this Post
 

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches here!

News & Commentary Rss Feed

Sector

Healthcare

Industry

Healthcare Information Services

Neostem, Inc. (NBS) Description

NeoStem Inc. is engaged in a platform business of operating a commercial autologous adult stem cell bank and is pioneering the pre-disease collection processing and long-term storage of stem cells from adult donors. Website: http://www.neostem.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks